Janus Henderson Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-61,069
Closed -$2.83M 2717
2021
Q4
$2.83M Buy
+61,069
New +$3.51M ﹤0.01% 1187
2021
Q3
Sell
-1,836
Closed -$196K 2228
2021
Q2
$196K Sell
1,836
-24,913
-93% -$2.95M ﹤0.01% 1579
2021
Q1
$4.07M Buy
26,749
+17,384
+186% +$2.83M ﹤0.01% 1045
2020
Q4
$1.57M Buy
9,365
+4,037
+76% +$718K ﹤0.01% 1158
2020
Q3
$834K Buy
+5,328
New +$1.07M ﹤0.01% 1162

Other funds holding TECX

Janus Henderson Group's TECX Position: Q1 2022 in Review

Janus Henderson Group sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 61,069 shares — an estimated $2.83M sold.

Janus Henderson Group first reported a position in TECX in Q3 2020 and held it in 5 quarters. The position peaked at $4.07M in Q1 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • Janus Henderson Group reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • Janus Henderson Group sold 61,069 Tectonic Therapeutic shares in Q1 2022, an estimated $2.83M.
  • Janus Henderson Group first reported a position in Tectonic Therapeutic in Q3 2020 and held it in 5 quarters.
  • Janus Henderson Group's Tectonic Therapeutic position peaked at $4.07M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.